Strategic AI Imaging Pact Propels SMLR 9.87% as Volume Surges to 407th U.S. Rank

On September 22, 2025, , , ranking it 407th among U.S. stocks by volume. The jump follows a strategic partnership announcement with a leading diagnostic technology firm, expanding its access to AI-driven imaging solutions for early-stage disease detection. The collaboration is expected to accelerate product development timelines by 12-18 months, according to internal estimates.

Analysts highlighted the stock's volatility as a double-edged sword: while the partnership validates SMLR’s market positioning, . Short-term traders have capitalized on the volume spike, .

Back-testing of a volume-based trading strategy reveals critical constraints. The proposed methodology—constructing a daily-rotating portfolio of the top 500 volume stocks and holding for one day—requires multi-asset data aggregation not yet supported by current tools. A practical alternative involves using broad-market ETFs as proxies, though this approach overlooks daily rebalancing effects. For precise replication, users must provide pre-processed signal files containing daily top-500 ticker lists for external performance calculation.